Tag: Derek Thomas

The below Parliamentary question was asked by Derek Thomas on 2016-06-15.

To ask the Secretary of State for International Development, what representations she has made to non-governmental organisations which receive funding from her Department on senior management salaries in those organisations.

Sir Desmond Swayne

The National Council for Voluntary Organisations, backed by the Charity Commission, has encouraged more transparency on pay issues and introduced new pay guidelines. DFID Ministers have consistently demanded that NGOs are transparent and open with donors and the public.

The below Parliamentary question was asked by Derek Thomas on 2015-11-10.

To ask the Secretary of State for Health, how much the NHS spends on treating age-related macular degeneration each year.

Alistair Burt

From the data collected it is not possible to identify how much was spent specifically on treating patients with age-related macular degeneration.

No estimate has been made of the annual cost of treating age related macular degeneration by 2050.

The below Parliamentary question was asked by Derek Thomas on 2016-02-11.

To ask the Secretary of State for Business, Innovation and Skills, what assessment the Government has made of the effect of the 2012 temporary liberalisation of Sunday trading regulations on its proposals for the devolution of such regulations to local authorities.

Anna Soubry

The ONS analysed the impact of the short term Olympic relaxation of the Sunday trading rules and found that it was not possible to make any inference from the data. They found no definite pattern amongst the growth rates of retail sales and noted that other factors, such as the weather and time of year, will have impacted sales.

In formulating its final proposals, the Government has carefully considered all the evidence submitted during the consultation process.

The below Parliamentary question was asked by Derek Thomas on 2016-07-11.

To ask the Secretary of State for Health, with reference to the Answer of 23 May 2016 to Question 37122, on variations in access to transcatheter interventions for heart valve disease, whether the next iteration of the NHS England service specifications and policy for the surgical and interventional treatment of heart valve disease will take into account (a) the need to commission for a growing patient population, (b) anticipated doubling in the over-65 population in the UK by 2050 and (c) lower levels of transcatheter interventions performed in the UK compared to European comparator countries.

Nicola Blackwood

NHS England’s policy development process includes assessment of current published evidence nationally and internationally and will review population projections for up to five years.

Decisions to set commissioning criteria for which patients will most likely benefit from the intervention will be based on a range of clinical, academic and financial information and a proposition will be put forward through the NHS England prioritisation process. Within the transcatheter aortic valve implantation (TAVI) development process, NHS England accepts that there is an ageing population and it will review all available evidence including the encouraging results of the TAVI trials and consider the options around the best use of National Health Service resources. A policy proposition will be produced as part of the 2016/17 work programme.

The below Parliamentary question was asked by Derek Thomas on 2015-11-10.

To ask the Secretary of State for Business, Innovation and Skills, what proportion of medical research spending is directed toward eye disease.

Joseph Johnson

I refer my hon. Friend to the answer I gave on 19 November 2015 to Question UIN 14200.

“

The below Parliamentary question was asked by Derek Thomas on 2016-03-23.

To ask the Secretary of State for Health, what assessment he has made of the direct effect of drug eluting stents on the reduction of lower limb amputations.

George Freeman

Vascular services manage the treatment and care of patients with diseases related to disorders of the arteries, veins and lymphatic system. These can be managed by medical therapy, minimally-invasive catheter procedures and surgical reconstruction. NHS England commissions these services as part of its specialised commissioning portfolio.

The vascular disease specialised commissioning clinical reference group has prepared a service specification for specialised vascular services. This aims to ensure that services deliver improved patient experience, provide equality of access to the full range of vascular diagnostics and interventions, and ensue that patients are receiving a high quality of service, with access to the most modern techniques.

Implementation of the service specification for specialised vascular services through the local service review processes is designed to reduce regional variation.

The service specification can be found at:

https://www.england.nhs.uk/wp-content/uploads/2013/06/a04-spec-vascu-adult.pdf

The Government has made no assessment of the effects of drug eluting stents on lower limb amputation rates.

“

The below Parliamentary question was asked by Derek Thomas on 2016-10-10.

To ask the Secretary of State for Health, what plans his Department has to replace or renew the National Stroke Strategy, published in December 2007.

David Mowat

The strategy remains valid and implementation of it continues. There are, therefore, no current plans to renew the national stroke strategy. Action is being taken to ensure the progress made on stroke continues. This includes:

– ongoing work in virtually all parts of the country to organise acute stroke care to ensure that all stroke patients, regardless of where they live or what time of the day or week they have their stroke, have access to high quality specialist care;

– publication of the Cardiovascular Disease (CVD) Outcomes Strategy in 2013, which includes many stroke specific strategic ambitions;

– a CVD expert forum, hosted by NHS England, to coordinate delivery of the work which was initiated in the CVD Outcomes Strategy; and

– NHS England’s National Clinical Director for Stroke works with the Strategic Clinical Networks, clinical commissioning groups, voluntary agencies and individual providers to support better commissioning and provision of stroke care.

More generally, the NHS Five Year Forward View recognises that quality of care, including stroke care, can be variable and that patients’ needs are changing and new treatment options are emerging. The Five Year Forward View sets out high level objectives to address these issues.

The below Parliamentary question was asked by Derek Thomas on 2015-11-10.

To ask the Secretary of State for Health, what estimate he has made of the likely annual cost to the NHS of treating age-related macular degeneration by 2050.

Alistair Burt

From the data collected it is not possible to identify how much was spent specifically on treating patients with age-related macular degeneration.

No estimate has been made of the annual cost of treating age related macular degeneration by 2050.

The below Parliamentary question was asked by Derek Thomas on 2016-03-23.

To ask the Secretary of State for Health, what steps he is taking to reduce regional variation of access to (a) minimally invasive technology and (b) drug eluting stents designed to tackle peripheral arterial disease.

George Freeman

Vascular services manage the treatment and care of patients with diseases related to disorders of the arteries, veins and lymphatic system. These can be managed by medical therapy, minimally-invasive catheter procedures and surgical reconstruction. NHS England commissions these services as part of its specialised commissioning portfolio.

The vascular disease specialised commissioning clinical reference group has prepared a service specification for specialised vascular services. This aims to ensure that services deliver improved patient experience, provide equality of access to the full range of vascular diagnostics and interventions, and ensue that patients are receiving a high quality of service, with access to the most modern techniques.

Implementation of the service specification for specialised vascular services through the local service review processes is designed to reduce regional variation.

The service specification can be found at:

https://www.england.nhs.uk/wp-content/uploads/2013/06/a04-spec-vascu-adult.pdf

The Government has made no assessment of the effects of drug eluting stents on lower limb amputation rates.

“

The below Parliamentary question was asked by Derek Thomas on 2016-10-11.

To ask the Secretary of State for Health, what assessment he has made of the potential effect of changes in funding for pharmacies on patient safety.

David Mowat

The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend the Secretary of State for Health under the National Health Service Act 2006. The latter includes the duty as to improvement in quality of services, such as the safety of services.

All pharmacists, pharmacy technicians and pharmacies in England are regulated by the General Pharmaceutical Council, which protects, promotes and maintains the health, safety and wellbeing of members of the public by upholding standards and public trust in pharmacy. Also, under NHS pharmaceutical services, community pharmacies are required to meet clinical governance requirements, which encourage continuing quality improvement, including through risk management.